KRAS and cyst: The feasibility of KRAS mutational status as a single marker has been evaluated in tissue, cyst fluid, duodenal fluid and plasma and does not appear to diagnose IPMNs or the level of cellular dysplasia consistently, being regarded as simply an early indicator of cell stress in pancreatic cells [67].